HIV and Inflammatory or Autoimmune Disease: Rare Patients Many Questions (MAIVIH)

  • STATUS
    Recruiting
  • End date
    Mar 18, 2023
  • participants needed
    400
  • sponsor
    Tourcoing Hospital
Updated on 18 September 2021
hepatitis
HIV Vaccine

Summary

Follow-up registry of patients living with HIV who also have various inflammatory and autoimmune pathologies that may require immunosuppressive treatment.

Details
Condition HIV, HIV positive, HIV infection, AIDS Vaccines, HIV Infections, human immunodeficiency virus, hiv disease, HIV Vaccine, hiv vaccines
Treatment Data Collection
Clinical Study IdentifierNCT05036811
SponsorTourcoing Hospital
Last Modified on18 September 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Patient living with HIV
Carrier of one or more of the following diseases
Sarcoidosis Multiple sclerosis Myasthenia gravis Crohn's disease Hemorrhagic
rectocolitis Autoimmune hepatitis Arthropathic psoriasis Still's disease
other rheumatoid arthritides, juvenile polyarthritides, Rheumatoid arthritis
Vasculitides: periarteritis nodosa and related conditions, other necrotizing
vasculopathies (periarteritis nodosa, juvenile periarteritis, Churg-Strauss
disease, polyangiitis, Kawasaki disease, Horton's disease, Wegener's disease
thrombotic microangiopathy, Takayashu syndrome, Good-Pasture's syndrome
thrombocytopenic purpura) Lupus Polymyositis or dermatopolymyositis
Connectivitis (Behcet's disease, Gougerot-Sjogren syndrome) Inflammatory
spondyloarthropathies (APS, spondyloarthritis, other spondyloarthropathies)

Exclusion Criteria

Opposition of the person
Minor patients
Patients under judicial protection
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note